de Carvalho D D, Schmitmeier S, Novello J C, Markland F S
Departamento de Bioquímica, Instituto de Biologia, UNICAMP, Campinas-SP, 13083-970, Brazil.
Toxicon. 2001 Oct;39(10):1471-6. doi: 10.1016/s0041-0101(01)00106-4.
Lectins are polyvalent carbohydrate-binding proteins of non-immune origin. Recently, we have isolated and characterized a lectin from the venom of the snake Bothrops jararacussu. This lectin (BJcuL) has been shown to bind to lactose moieties and induce agglutination of erythrocytes. In the present work, we observed that cells from human metastatic breast cancer (MDA-MB-435) and human ovarian carcinoma (OVCAR-5) cell lines adhere, although weakly, to BJcuL. However, BJcuL did not inhibit adhesion of these cells to the extracellular matrix proteins fibronectin, laminin and type I collagen. Importantly, viability of these tumor cells and cells from other human tumor cell lines and a bovine brain endothelial cell line was suppressed by BJcuL. These findings suggest that the lectin BJcuL may serve as an interesting tool for combating tumor progression by inhibiting tumor cell and endothelial cell growth.
凝集素是一种非免疫来源的多价碳水化合物结合蛋白。最近,我们从蛇类巴西矛头蝮(Bothrops jararacussu)的毒液中分离并鉴定了一种凝集素。这种凝集素(BJcuL)已被证明能与乳糖部分结合并诱导红细胞凝集。在本研究中,我们观察到来自人转移性乳腺癌(MDA-MB-435)和人卵巢癌(OVCAR-5)细胞系的细胞虽然与BJcuL的黏附较弱,但仍能黏附。然而,BJcuL并不抑制这些细胞与细胞外基质蛋白纤连蛋白、层粘连蛋白和I型胶原的黏附。重要的是,BJcuL可抑制这些肿瘤细胞以及来自其他人类肿瘤细胞系和牛脑内皮细胞系的细胞的活力。这些发现表明,凝集素BJcuL可能是一种通过抑制肿瘤细胞和内皮细胞生长来对抗肿瘤进展的有趣工具。